Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-31 00:00:00 ET · period of report 2021-08-27 · accession 0001708138-21-000068 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-31 | 2021-08-27 | REGN | POON CHRISTINE A | Dir | M - OptEx | $57.11 | +15.0K | 16.7K | +892% | +$856.6K |
| DM | 2021-08-31 | 2021-08-27 | REGN | POON CHRISTINE A | Dir | S - Sale+OE | $668.09 | -15.0K | 13.6K | -52% | -$10.02M |
| D | 2021-08-31 | 2021-08-27 | REGN | POON CHRISTINE A | Dir | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-27 | M | A | 15,000 | $57.11 | 16,681 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-27 | S | D | 1,737 | $671.49 | 1,793 | D | — | — | (F9) Represents volume-weighted average price of sales of 1,737 shares of Company stock on August 27, 2021 at prices ranging from $671.00 to $671.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-08-27 | S | D | 3,447 | $670.48 | 3,530 | D | — | — | (F8) Represents volume-weighted average price of sales of 3,447 shares of Company stock on August 27, 2021 at prices ranging from $670.01 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-08-27 | S | D | 2,235 | $669.59 | 6,977 | D | — | — | (F7) Represents volume-weighted average price of sales of 2,235 shares of Company stock on August 27, 2021 at prices ranging from $669.17 to $669.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-08-27 | S | D | 603 | $668.33 | 9,212 | D | — | — | (F6) Represents volume-weighted average price of sales of 603 shares of Company stock on August 27, 2021 at prices ranging from $668.04 to $668.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 6 | Common | Common Stock | 2021-08-27 | S | D | 2,150 | $667.37 | 9,815 | D | — | — | (F5) Represents volume-weighted average price of sales of 2,150 shares of Company stock on August 27, 2021 at prices ranging from $667.01 to $667.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 7 | Common | Common Stock | 2021-08-27 | S | D | 1,118 | $666.70 | 11,965 | D | — | — | (F4) Represents volume-weighted average price of sales of 1,118 shares of Company stock on August 27, 2021 at prices ranging from $666.39 to $666.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-08-27 | S | D | 538 | $665.33 | 13,083 | D | — | — | (F3) Represents volume-weighted average price of sales of 538 shares of Company stock on August 27, 2021 at prices ranging from $665.07 to $665.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-08-27 | S | D | 112 | $672.27 | 1,681 | D | — | — | (F10) Represents volume-weighted average price of sales of 112 shares of Company stock on August 27, 2021 at prices ranging from $672.27 to $672.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-08-27 | S | D | 100 | $662.62 | 16,581 | D | — | — | |
| 11 | Common | Common Stock | 2021-08-27 | S | D | 2,260 | $663.51 | 14,321 | D | — | — | (F1) Represents volume-weighted average price of sales of 2,260 shares of Company stock on August 27, 2021 at prices ranging from $663.11 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 12 | Common | Common Stock | 2021-08-27 | S | D | 700 | $664.42 | 13,621 | D | — | — | (F2) Represents volume-weighted average price of sales of 700 shares of Company stock on August 27, 2021 at prices ranging from $664.00 to $664.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price. |
| 13 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-27 | M | D | 15,000 | $0.00 | 0 | D | $57.11 · — to 2022-01-03 | 15,000 Common Stock | (F11) The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |